XML 14 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 245,641 $ 286,503
Accounts receivable, net 96,388 83,533
Inventory 77,536 70,694
Prepaid expenses and other current assets 8,469 9,648
Total current assets 428,034 450,378
Restricted cash, non-current 3,038 3,038
Property and equipment, net 31,739 30,399
Operating lease right-of-use assets, net 17,162 17,538
Intangible assets, net 640 709
Other assets 6,449 6,019
Total assets 487,062 508,081
Current liabilities:    
Accounts payable 18,851 17,285
Accrued compensation 18,476 23,175
Deferred revenue 13,702 13,048
Operating lease, current 2,358 2,214
Other current liabilities 10,249 10,073
Total current liabilities 63,636 65,795
Long-term debt 51,664 51,615
Operating lease, non-current 23,974 24,654
Other non-current liabilities 121 147
Total liabilities 139,395 142,211
Commitments and contingencies (see Note 11)
Stockholders’ equity:    
Preferred stock, $0.00001 par value; Authorized shares: 10,000 at March 31, 2026 and December 31, 2025 Issued and outstanding shares: none at March 31, 2026 and December 31, 2025 0 0
Common stock, $0.00001 par value; Authorized shares: 300,000 at March 31, 2026 and December 31, 2025 Issued and outstanding shares: 56,323 and 56,323 at March 31, 2026 and December 31, 2025, respectively 0 0
Additional paid-in capital 1,020,881 1,007,390
Accumulated other comprehensive gain (loss) (19) 37
Accumulated deficit (673,195) (641,557)
Total stockholders’ equity 347,667 365,870
Total liabilities and stockholders’ equity $ 487,062 $ 508,081